Publications

• The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated Toxicities.
  Transplant Cell Ther Volume: 31 Page(s): 109.e1 - 109.e13
  02/01/2025 Authors: Takahashi T; Watkins B; Bratrude B; Neuberg D; Hebert K; Betz K; Yu A; Choi SW; Davis J; Duncan C
• Abatacept for acute graft-versus-host disease prophylaxis after unrelated donor hematopoietic cell transplantation.
  Blood Volume: 144 Page(s): 1834 - 1845
  10/24/2024 Authors: Kean LS; Burns LJ; Kou TD; Kapikian R; Lozenski K; Langston A; Horan JT; Watkins B; Qayed M; Bratrude B
• Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHD.
  Bone Marrow Transplant Volume: 59 Page(s): 680 - 687
  05/01/2024 Authors: Gorfinkel L; Raghunandan S; Watkins B; Hebert K; Neuberg DS; Bratrude B; Betz K; Yu A; Choi SW; Davis J
• Abatacept for graft versus host disease prophylaxis in patients 60 years and older receiving mismatched unrelated donor transplantation for hematologic malignancies.
  Bone Marrow Transplant Volume: 58 Page(s): 1264 - 1266
  11/01/2023 Authors: Raghunandan S; Qayed M; Watkins BK; Graiser M; Gorfinkel L; Westbrook A; Gillespie S; Bratrude B; Petrovic A; Suessmuth Y
• Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis.
  Bone Marrow Transplant Volume: 58 Page(s): 1260 - 1263
  11/01/2023 Authors: Raghunandan S; Gorfinkel L; Bratrude B; Suessmuth Y; Hebert K; Neuberg D; Williams KM; Schoettler ML; Langston AA; Kean LS
• Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events.
  Blood Volume: 142 Page(s): 700 - 710
  08/24/2023 Authors: Takahashi T; Al-Kofahi M; Jaber M; Bratrude B; Betz K; Suessmuth Y; Yu A; Neuberg DS; Choi SW; Davis J
• Abatacept for the prevention of GVHD in patients receiving mismatched unrelated transplants: a real-world analysis.
  Blood Adv Volume: 7 Page(s): 4395 - 4399
  08/22/2023 Authors: Raghunandan S; Gorfinkel L; Graiser M; Bratrude B; Suessmuth Y; Gillespie S; Westbrook AL; Williams KM; Schoettler ML; Kean LS
• Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure.
  Blood Adv Volume: 7 Page(s): 2196 - 2205
  05/23/2023 Authors: Stenger EO; Watkins B; Rogowski K; Chiang K-Y; Haight A; Leung K; Qayed M; Raghunandan S; Suessmuth Y; Kean L
• Long-Term Organ Function After HCT for SCD: A Report From the Sickle Cell Transplant Advocacy and Research Alliance.
  Transplant Cell Ther Volume: 29 Page(s): 47.e1 - 47.e10
  01/01/2023 Authors: Stenger E; Xiang Y; Wetzel M; Gillespie S; Chellapandian D; Shah R; Arnold SD; Bhatia M; Chaudhury S; Eckrich MJ
• Overlap chronic graft-versus-host disease (GvHD) is associated aith an adverse prognosis: secondary analysis of the ABA2 trial
  Volume: 57 Page(s): 41 - 41
  11/01/2022 Authors: Gorfinkel L; Raghunandan S; Langston A; Westbrook A; Gillespie S; Bratrude B; Betz K; Choi SW; Davis J; Duncan C
• Hematopoietic Cell Transplantation in the Treatment of Pediatric Acute Myelogenous Leukemia and Myelodysplastic Syndromes: Guidelines from the American Society of Transplantation and Cellular Therapy.
  Transplant Cell Ther Volume: 28 Page(s): 530 - 545
  09/01/2022 Authors: Tarlock K; Sulis ML; Chewning JH; Pollard JA; Cooper T; Gamis A; Shenoy S; Kutny M; Horan J; Meshinchi S
• ABATACEPT FOR THE PREVENTION OF GVHD IN PEDIATRIC PATIENTS RECEIVING 7/8 HLA-MISMATCHED TRANSPLANT
  Volume: 69
  06/01/2022 Authors: Raghunandan S; Gorfinkel L; Bratrude B; Betz K; Suessmuth Y; Gillespie S; Westbrook A; Williams K; Schoettler M; Langston A
• Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation.
  Blood Adv Volume: 6 Page(s): 746 - 749
  02/08/2022 Authors: Qayed M; Watkins B; Gillespie S; Bratrude B; Betz K; Choi SW; Davis J; Duncan C; Giller R; Grimley M
• Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD.
  J Clin Oncol Volume: 39 Page(s): 1865 - 1877
  06/10/2021 Authors: Watkins B; Qayed M; McCracken C; Bratrude B; Betz K; Suessmuth Y; Yu A; Sinclair S; Furlan S; Bosinger S
• RIFAXIMIN TO PREVENT BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT)
  Volume: 68 Page(s): S105 - S105
  06/01/2021 Authors: Teherani M; Gillespie S; Pratte Z; Banksota S; Gulick D; Djeddar N; Chahroudi A; Horan J; Gibson G; Qayed M
• Hematopoietic stem cell transplant referral patterns for children with sickle cell disease vary among pediatric hematologist/oncologists' practice focus: A Sickle Cell Transplant Advocacy and Research Alliance (STAR) study.
  Pediatr Blood Cancer Volume: 68 Page(s): e28861
  03/01/2021 Authors: Meier ER; Abraham AA; Ngwube A; Janson IA; Guilcher GMT; Horan J; Kasow KA
• Spatiotemporal single-cell profiling reveals that invasive and tissue-resident memory donor CD8+ T cells drive gastrointestinal acute graft-versus-host disease.
  Sci Transl Med Volume: 13
  01/13/2021 Authors: Tkachev V; Kaminski J; Potter EL; Furlan SN; Yu A; Hunt DJ; McGuckin C; Zheng H; Colonna L; Gerdemann U
• Predicting Immune Pathology after Hematopoietic Stem Cell Transplant with Transcriptomics: Naive CD4 T Cell Expansion at Day 100 Predicts Patients with De Novo Chronic Gvhd
  Volume: 136
  11/05/2020 Authors: Watkins B; Kaminski J; Qayed M; Betz K; Suessmuth Y; Bratrude B; Yu A; Tkachev V; Pellegrini K; Bosinger S
• Potent Interaction between CMV Reactivation and Gvhd: Immunologic Evidence for Blunting of CMV-Driven Immune Reconstitution in the Setting of Gvhd
  Volume: 136
  11/05/2020 Authors: Suessmuth Y; Betz K; Yu A; Bratrude B; Watkins B; Qayed M; Horan JT; Kean L; Langston A
• Potent interaction between CMV reactivation and GVHD: Immunologic evidence for the blunting of CMV-driven immune reconstitution in the setting of GVHD in transplant patients
  Volume: 204
  05/01/2020 Authors: Suessmuth Y; Betz K; Yu A; Bratrude B; Watkins B; Qayed M; Horan J; Kean LS; Langston A
• Human leukocyte antigen (HLA) class I antibodies and transfusion support in paediatric HLA-matched haematopoietic cell transplant for sickle cell disease.
  Br J Haematol Volume: 189 Page(s): 162 - 170
  04/01/2020 Authors: Nickel RS; Horan JT; Abraham A; Qayed M; Haight A; Ngwube A; Liang H; Luban NLC; Hendrickson JE
• Abatacept for Gvhd Prophylaxis after Hematopoietic Cell Transplantation (HCT) for Pediatric Sickle Cell Disease (SCD): A Sickle Cell Transplant Advocacy and Research Alliance (STAR) Trial
  Volume: 26 Page(s): S20 - S20
  03/01/2020 Authors: Chaudhury S; Volonte B; Rangarajan HG; Horan J; Haight AE; Abraham A; Ngwube A; Krajewski J; Guilcher GMT; Bhatia M
• Mixed-phenotype acute leukemia: A cohort and consensus research strategy from the Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task Force.
  Cancer Volume: 126 Page(s): 593 - 601
  02/01/2020 Authors: Orgel E; Alexander TB; Wood BL; Kahwash SB; Devidas M; Dai Y; Alonzo TA; Mullighan CG; Inaba H; Hunger SP
• Pediatric Hematologist/Oncologists' Beliefs about Hematopoietic Stem Cell Transplant for Children with Sickle Cell Disease: A Sickle Cell Transplant Advocacy and Research Alliance (STAR) Study
  Volume: 134
  11/13/2019 Authors: Meier ER; Abraham A; Ngwube AI; Janson I; Guilcher GMT; Horan JT; Kasow KA
• Transcriptomic Analysis of CD4+T Cell Dysfunction during Gvhd: Evidence for Profound Reprograming of T Cell Signaling during Acute Gvhd That Is Controlled during CD28:CD80/86 Costimulation Blockade with Abatacept
  Volume: 134
  11/13/2019 Authors: Watkins B; Suessmuth Y; Betz K; Yu A; Bratrude B; Qayed M; Pellegrini K; Bosinger S; Langston A; Horan JT
• T cell costimulation blockade with abatacept for acute graft-versus-host disease prevention in matched and mismatched unrelated donor transplantation: Results of the first phase 2 trial
  Volume: 54 Page(s): 81 - 82
  07/01/2019 Authors: Qayed M; Watkins B; Bratrude B; Betz K; Rhodes J; Sinclair S; Suessmuth Y; Yu A; Dean C; Cribbin K
• Donor-specific anti-HLA antibodies in unrelated hematopoietic cell transplantation for non-malignant disorders.
  Bone Marrow Transplant Volume: 54 Page(s): 494 - 496
  03/01/2019 Authors: Woolfrey A; Wang T; Lee SJ; Haagenson MD; Chen G; Fleischhauer K; Horan J; Hsu K; Verneris M; Spellman SR
• The genetic basis and cell of origin of mixed phenotype acute leukaemia.
  Nature Volume: 562 Page(s): 373 - 379
  10/01/2018 Authors: Alexander TB; Gu Z; Iacobucci I; Dickerson K; Choi JK; Xu B; Payne-Turner D; Yoshihara H; Loh ML; Horan J
• Allogeneic Mesenchymal Stromal Cells (MSCs) are of Comparable Efficacy to Syngeneic MSCs for Therapeutic Revascularization in C57BKSdb/db Mice Despite the Induction of Alloantibody.
  Cell Transplant Volume: 27 Page(s): 1210 - 1221
  08/01/2018 Authors: Liew A; Baustian C; Thomas D; Vaughan E; Sanz-Nogus C; Creane M; Chen X; Alagesan S; Owens P; Horan J
• Treatment strategies for adolescent and young adult patients with acute myeloid leukemia.
  Blood Volume: 132 Page(s): 362 - 368
  07/26/2018 Authors: O'Dwyer K; Freyer DR; Horan JT
• Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis.
  Biol Blood Marrow Transplant Volume: 24 Page(s): 521 - 528
  03/01/2018 Authors: Qayed M; Wang T; Hemmer MT; Spellman S; Arora M; Couriel D; Alousi A; Pidala J; Abdel-Azim H; Aljurf M
• Abatacept for GVHD Prophylaxis after Hematopoietic Stem Cell Transplantation (HCT) for Pediatric Sickle Cell Disease (SCD): A Sickle Transplant Alliance for Research (STAR) Trial
  Volume: 24 Page(s): S86 - S86
  03/01/2018 Authors: Chaudhury S; Laskowski J; Rangarajan HG; Abraham A; Haight AE; Guilcher GMT; Sosna J; Robinson C; Horan J; Bhatia M
• Early blood stream infection following allogeneic hematopoietic stem cell transplantation is a risk factor for acute grade III-IV GVHD in children and adolescents.
  Pediatr Blood Cancer Volume: 65
  02/01/2018 Authors: Sano H; Hilinski JA; Qayed M; Applegate K; Newton JG; Watkins B; Chiang K-Y; Horan J
• Isolated myeloperoxidase expression in pediatric B/myeloid mixed phenotype acute leukemia is linked with better survival.
  Blood Volume: 131 Page(s): 573 - 577
  02/01/2018 Authors: Raikar SS; Park SI; Leong T; Jaye DL; Keller FG; Horan JT; Woods WG
• Isolated Myeloperoxidase Expression in Pediatric B/Myeloid Mixed Phenotype Acute Leukemia Is Associated with Improved Survival Using ALL-Only Regimens
  Volume: 130
  12/07/2017 Authors: Raikar SS; Park S; Leong T; Jaye DL; Keller FG; Horan JT; Woods WG
• Similar Event-Free Survival but Higher Incidence of Mixed T Cell Chimerism after Hematopoietic Cell Transplantation for Sickle Cell Disease Using Rabbit Versus Horse ATG: a Study from the Sickle Transplant Alliance for Research (STAR)
  Volume: 130
  12/07/2017 Authors: Abraham A; Stenger E; Travers CD; Nickel R; Rangarajan HG; Krajewski J; Chaudhury S; Kasow KA; Quigg TC; Ngwube AI
• CD36-positive B-lymphoblasts Predict Poor Outcome in Children With B-lymphoblastic Leukemia.
  Pediatr Dev Pathol Volume: 20 Page(s): 224 - 231
  06/01/2017 Authors: Newton JG; Horan JT; Newman S; Rossi MR; Ketterling RP; Park SI
• Recipient and donor age impact the risk of developing chronic GvHD in children after allogeneic hematopoietic transplant.
  Bone Marrow Transplant Volume: 52 Page(s): 625 - 626
  04/01/2017 Authors: Watkins BK; Horan J; Storer B; Martin PJ; Carpenter PA; Flowers MED
• African American Race Is a Newly Identified Risk Factor for Postengraftment Blood Stream Infections in Pediatric Allogeneic Blood and Marrow Transplantation.
  Biol Blood Marrow Transplant Volume: 23 Page(s): 357 - 360
  02/01/2017 Authors: Sano H; Hilinski JA; Applegate K; Chiang K-Y; Haight A; Qayed M; Horan J
• Influence of Age on Risk for Acute and Chronic Graft Versus Host Disease in Children Receiving HLA Identical Sibling Bone Marrow Transplantation
  Volume: 128
  12/02/2016 Authors: Qayed M; Horan J; Spellman SR; Arora M; Wang T; Hemmer M; Pidala JA; Couriel D; Alousi AM
• CMV Viremia and African-American Ethnicity Are Risk Factors for Post-Engraftment Blood Stream Infections in Pediatric Allogeneic Blood and Marrow Transplantation
  Volume: 128
  12/02/2016 Authors: Sano H; Hilinski J; Applegate K; Camacho-Gonzalez A; Chandrakasan S; Chiang K-Y; Haight A; Krishnamurti L; Stenger E; Qayed M
• Leukoreduced red blood cell transfusions do not induce platelet glycoprotein antibodies in patients with sickle cell disease.
  Transfusion Volume: 56 Page(s): 2267 - 2273
  09/01/2016 Authors: Nickel RS; Winkler AM; Horan JT; Hendrickson JE
• Haematopoietic stem cell transplantation for sickle cell disease - current practice and new approaches.
  Br J Haematol Volume: 174 Page(s): 515 - 525
  08/01/2016 Authors: Arnold SD; Bhatia M; Horan J; Krishnamurti L
• Improved Splenic Function After Hematopoietic Stem Cell Transplant for Sickle Cell Disease.
  Volume: 63 Page(s): 908 - 913
  05/01/2016 Authors: Nickel RS; Seashore E; Lane PA; Alazraki AL; Horan JT; Bhatia M; Haight AE
• Immunophenotypic parameters and RBC alloimmunization in children with sickle cell disease on chronic transfusion.
  Am J Hematol Volume: 90 Page(s): 1135 - 1141
  12/01/2015 Authors: Nickel RS; Horan JT; Fasano RM; Meyer E; Josephson CD; Winkler AM; Yee MEM; Kean LS; Hendrickson JE
• Use of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases.
  Biol Blood Marrow Transplant Volume: 21 Page(s): 1845 - 1852
  10/01/2015 Authors: Stenger EO; Chiang K-Y; Haight A; Qayed M; Kean L; Horan J
• Red blood cell transfusions are associated with HLA class I but not H-Y alloantibodies in children with sickle cell disease.
  Br J Haematol Volume: 170 Page(s): 247 - 256
  07/01/2015 Authors: Nickel RS; Hendrickson JE; Yee MM; Bray RA; Gebel HM; Kean LS; Miklos DB; Horan JT
• CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCR repertoire.
  Blood Volume: 125 Page(s): 3835 - 3850
  06/18/2015 Authors: Suessmuth Y; Mukherjee R; Watkins B; Koura DT; Finstermeier K; Desmarais C; Stempora L; Horan JT; Langston A; Qayed M
• Immune parameter analysis of children with sickle cell disease on hydroxycarbamide or chronic transfusion therapy.
  Br J Haematol Volume: 169 Page(s): 574 - 583
  05/01/2015 Authors: Nickel RS; Osunkwo I; Garrett A; Robertson J; Archer DR; Promislow DEL; Horan JT; Hendrickson JE; Kean LS
• Using fludarabine to reduce exposure to alkylating agents in children with sickle cell disease receiving busulfan, cyclophosphamide, and antithymocyte globulin transplant conditioning: results of a dose de-escalation trial.
  Biol Blood Marrow Transplant Volume: 21 Page(s): 900 - 905
  05/01/2015 Authors: Horan JT; Haight A; Dioguardi JL; Brown C; Grizzle A; Shelman C; Kanter J; Hale G; Nieder M; Benton M
• A Multi-Institutional Retrospective Data Analysis of Hematopoietic Cell Transplantation for Less Severe Sickle Cell Disease
  Volume: 21 Page(s): S95 - S95
  02/01/2015 Authors: Dioguardi J; Abraham A; Horan J; Briamonte C; Chiang K-Y; Bhatia M
• Exhaustive TCR Deep Sequencing Reveals That CMV Reactivation Fundamentally Resets Immune Reconstitution after Transplant and Results in Significant Deficits in the Effector Memory TCR Repertoire
  Volume: 21 Page(s): S69 - S70
  02/01/2015 Authors: Suessmuth Y; Koura D; Finstermeier K; Desmarais C; Horan J; Langston A; Qayed M; Khoury HJ; Watkins BK; Robins H
• Risk for CMV reactivation in children undergoing allogeneic hematopoietic stem cell transplantation.
  Pediatr Blood Cancer Volume: 62 Page(s): 364 - 366
  02/01/2015 Authors: Qayed M; Khurana M; Hilinski J; Gillespie S; McCracken C; Applegate K; Chiang K-Y; Horan J
• The Role of Intestinal Microbiota in Graft versus Host Disease.
  Mini Rev Med Chem Volume: 16 Page(s): 193 - 199
  01/01/2015 Authors: Qayed M; Horan JT
• Alemtuzumab, Belatacept and Sirolimus: A Path to Monotherapy Belatacept
  Volume: 98 Page(s): 80 - 80
  07/15/2014 Authors: Kirk A; Guasch A; Xu H; Cheeseman J; Mead S; Ghali A; Mehta A; Gebel H; Bray R; Horan J
• Relative defects in mucosal immunity predict acute graft-versus-host disease.
  Biol Blood Marrow Transplant Volume: 20 Page(s): 1056 - 1059
  07/01/2014 Authors: August KJ; Chiang K-Y; Qayed M; Dulson A; Worthington-White D; Cole CR; Horan JT
• Alemtuzumab, Belatacept and Sirolimus: A Path to Monotherapy Belatacept
  Volume: 14 Page(s): 80 - 80
  06/01/2014 Authors: Kirk A; Guasch A; Xu H; Cheeseman J; Mead S; Ghali A; Mehta A; Gebel H; Bray R; Horan J
• Outcome of transplantation for acute lymphoblastic leukemia in children with Down syndrome.
  Pediatr Blood Cancer Volume: 61 Page(s): 1126 - 1128
  06/01/2014 Authors: Hitzler JK; He W; Doyle J; Cairo M; Camitta BM; Chan KW; Diaz Perez MA; Fraser C; Gross TG; Horan JT
• EXPRESSION OF CD36 AND THE PRESENCE OF CYTOPLASMIC GRANULES IN BLASTS PREDICTS POOR PROGNOSIS IN CHILDREN WITH B-LYMPHOBLASTIC LEUKEMIA
  PEDIATRIC BLOOD & CANCER Volume: 61 Page(s): S53 - S53
  05/01/2014 Authors: Newton J; Horan J; Cooper T; Rossi M; Park S
• Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors.
  Am J Transplant Volume: 14 Page(s): 1142 - 1151
  05/01/2014 Authors: Kirk AD; Guasch A; Xu H; Cheeseman J; Mead SI; Ghali A; Mehta AK; Wu D; Gebel H; Bray R
• Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens.
  Blood Volume: 123 Page(s): 1615 - 1620
  03/06/2014 Authors: Bitan M; He W; Zhang M-J; Abdel-Azim H; Ayas MF; Bielorai B; Carpenter PA; Cairo MS; Diaz MA; Horan JT
• Comparable survival for pediatric acute myeloid leukemia with poor-risk cytogenetics following chemotherapy, matched related donor, or unrelated donor transplantation.
  Pediatr Blood Cancer Volume: 61 Page(s): 269 - 275
  02/01/2014 Authors: Kelly MJ; Horan JT; Alonzo TA; Eapen M; Gerbing RB; He W; Lange BJ; Parsons SK; Woods WG
• Effect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemia.
  Am J Hematol Volume: 89 Page(s): 125 - 129
  02/01/2014 Authors: Eckrich MJ; Ahn K-W; Champlin RE; Coccia P; Godder K; Horan J; Margolis D; Deeg HJ; Eapen M
• Outcome of adolescents and young adults with acute myeloid leukemia treated on COG trials compared to CALGB and SWOG trials.
  Cancer Volume: 119 Page(s): 4170 - 4179
  12/01/2013 Authors: Woods WG; Franklin ARK; Alonzo TA; Gerbing RB; Donohue KA; Othus M; Horan J; Appelbaum FR; Estey EH; Bloomfield CD
• Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients: a report from the Children's Oncology Group.
  Cancer Volume: 119 Page(s): 4162 - 4169
  12/01/2013 Authors: Canner J; Alonzo TA; Franklin J; Freyer DR; Gamis A; Gerbing RB; Lange BJ; Meshinchi S; Woods WG; Perentesis J
• Alterations In Specific Immune Cell Subsets In Children With Sickle Cell Disease
  Volume: 122
  11/15/2013 Authors: Nickel RS; Hendrickson JE; Horan JT; Garrett AP; Robertson JM; Osunkwo I; Kean LS
• Alloimmunization To HLA Class I Antigens But Not H-Y Antigens Is Associated With Transfusion In Children With Sickle Cell Disease
  Volume: 122
  11/15/2013 Authors: Nickel RS; Hendrickson JE; Kean LS; Yee MEM; Bray RA; Gebel HM; Miklos DB; Horan JT
• In vivo T cell costimulation blockade with abatacept for acute graft-versus-host disease prevention: a first-in-disease trial.
  Biol Blood Marrow Transplant Volume: 19 Page(s): 1638 - 1649
  11/01/2013 Authors: Koura DT; Horan JT; Langston AA; Qayed M; Mehta A; Khoury HJ; Harvey RD; Suessmuth Y; Couture C; Carr J
• The impact of HLA unidirectional mismatches on the outcome of myeloablative hematopoietic stem cell transplantation with unrelated donors.
  Blood Volume: 121 Page(s): 4800 - 4806
  06/06/2013 Authors: Hurley CK; Woolfrey A; Wang T; Haagenson M; Umejiego J; Aljurf M; Askar M; Battiwalla M; Dehn J; Horan J
• Outcome of transplantation for acute myelogenous leukemia in children with Down syndrome.
  Biol Blood Marrow Transplant Volume: 19 Page(s): 893 - 897
  06/01/2013 Authors: Hitzler JK; He W; Doyle J; Cairo M; Camitta BM; Chan KW; Diaz Perez MA; Fraser C; Gross TG; Horan JT
• Rifaximin for preventing acute graft-versus-host disease: impact on plasma markers of inflammation and T-cell activation.
  J Pediatr Hematol Oncol Volume: 35 Page(s): e149 - e152
  05/01/2013 Authors: Qayed M; Langston A; Chiang K-Y; August K; Hilinski JA; Cole CR; Rogatko A; Bostick RM; Horan JT
• A First-in-Disease Trial of in Vivo Costimulation Blockade for GVHD Prevention: The Addition of Abatacept to Standard GVHD Prophylaxis Controls Early CD4+T Cell Proliferation and is Associated with Low Rates of Severe Acute GVHD
  Volume: 19 Page(s): S327 - S328
  02/01/2013 Authors: Tiwari D; Horan J; Langston A; Qayed M; Carr J; Renfroe H; Couture C; Khoury HJ; Robertson J; Harvey D
• Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders.
  Blood Volume: 120 Page(s): 2918 - 2924
  10/04/2012 Authors: Horan J; Wang T; Haagenson M; Spellman SR; Dehn J; Eapen M; Frangoul H; Gupta V; Hale GA; Hurley CK
• IMPACT OF HLA UNIDIRECTIONAL MISMATCHES ON THE OUTCOME OF UNRELATED DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION
  Volume: 79 Page(s): 407 - 407
  06/01/2012 Authors: Hurley CK; Wang T; Spellman SR; Umejiego J; Aljurf M; Askar M; Battiwalla M; Dehn J; Horan J; Marino SR
• The deceased organ donor with an "open abdomen": proceed with caution.
  Transpl Infect Dis Volume: 14 Page(s): 311 - 315
  06/01/2012 Authors: Watkins AC; Vedula GV; Horan J; Dellicarpini K; Pak S-W; Daly T; Samstein B; Kato T; Emond JC; Guarrera JV
• CD28-Directed Costimulation Blockade with Abatacept To Prevent GvHD during High-Risk Unrelated BMT: A First-in-Disease Trial
  Volume: 12 Page(s): 34 - 34
  05/01/2012 Authors: Kean L; Tiwari D; Mehta A; Sen S; Robertson J; Carr J; Renfroe H; Langston A; Waller E; Horan J
• Kidney Transplantation Using Alemtuzumab Induction and Belatacept/Sirolimus Maintenance Therapy
  Volume: 12 Page(s): 197 - 197
  05/01/2012 Authors: Kirk AD; Mehta AK; Guasch A; Mead S; Xu H; Cheeseman J; Horan J; Kean L; Larsen CP; Pearson TC
• CD28-DIRECTED T CELL COSTIMULATION BLOCKADE WITH ABATACEPT TO PREVENT GVHD DURING HIGH-RISK UNRELATED HSCT: A FIRST-IN-DISEASE TRIAL
  Volume: 18 Page(s): S365 - S365
  02/01/2012 Authors: Kean LS; Langston A; Qayed M; Khoury J; Tiwari D; Couture C; Renfroe H; Sen S; Robertson I; Waller EK
• TARGETING MEMORY T CELLS WITH ALEFACEPT TO ABROGATE TRANSFUSION ALLOIMMUNIZATION: PRELIMINARY RESULTS FROM A TRIAL OF REDUCED INTENSITY CONDITIONING AND ALLOGENEIC TRANSPLANT FOR CHILDREN WITH NON-MALIGNANT HEMATOLOGIC DISEASES
  Volume: 18 Page(s): S325 - S325
  02/01/2012 Authors: Horan JT; Qayed M; Haight A; Couture C; Chiang KY; Kean L
• CD28-Directed T Cell Costimulation Blockade with Abatacept to Prevent GvHD During High-Risk Unrelated HSCT: A First-in-Disease Feasibility Trial
  Volume: 118 Page(s): 1741 - 1742
  11/18/2011 Authors: Kean LS; Langston A; Qayad M; Khoury HJ; Tiwari D; Couture C; Renfroe H; Sen S; Robertson J; Waller EK
• Red-Cell Transfusion Events as a Risk Factor for Sinusoidal Obstruction Syndrome in Children with Neuroblastoma Undergoing Hematopoietic Stem Cell Transplant
  Volume: 51 Page(s): 113A - 113A
  09/01/2011 Authors: Andrews JC; Qayed M; Applegate K; Jessup P; Horan J; Katzenstein H; Josephson C
• LOWER OVERALL SURVIVAL IN AFRICAN AMERICAN PATIENTS UNDERGOING UNRELATED UMBILICAL CORD BLOOD TRANSPLANT: RESULTS OF A SINGLE INSTITUTION RETROSPECTIVE ANALYSIS
  PEDIATRIC BLOOD & CANCER Volume: 56 Page(s): 903 - 904
  06/01/2011 Authors: Pauly M; Andrews J; Applegate K; Chiang K-Y; Couture C; Haight A; Li R; Kean L; Qayed M; Horan J
• HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation.
  Biol Blood Marrow Transplant Volume: 17 Page(s): 885 - 892
  06/01/2011 Authors: Woolfrey A; Klein JP; Haagenson M; Spellman S; Petersdorf E; Oudshoorn M; Gajewski J; Hale GA; Horan J; Battiwalla M
• Treatment outcomes in older adolescent and young adult (AYA) patients with newly diagnosed AML.
  JOURNAL OF CLINICAL ONCOLOGY Volume: 29
  05/20/2011 Authors: Canner JA; Alonzo TA; Franklin J; Freyer DR; Gamis AS; Gerbing RB; Lange B; Meshinchi S; Woods WG; Perentesis JP
• Biomarkers of immune activation to screen for severe, acute GVHD.
  Bone Marrow Transplant Volume: 46 Page(s): 601 - 604
  04/01/2011 Authors: August KJ; Chiang K-Y; Bostick RM; Flanders WD; Waller EK; Langston A; Worthington-White D; Rowland P; Moore KF; Khoury HJ
• Kidney Transplantation Using Alemtuzumab Induction and Belatacept/Sirolimus Maintenance Therapy.
  Volume: 11 Page(s): 45 - 45
  04/01/2011 Authors: Kirk AD; Mead S; Xu H; Mehta A; Guasch A; Cheeseman J; Joseph J; Horan J; Kean L; Larsen CP
• Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?
  J Clin Oncol Volume: 29 Page(s): 805 - 813
  03/01/2011 Authors: Horan JT; Logan BR; Agovi-Johnson M-A; Lazarus HM; Bacigalupo AA; Ballen KK; Bredeson CN; Carabasi MH; Gupta V; Hale GA
• HLA-matched sibling bone marrow transplantation for -thalassemia major.
  Blood Volume: 117 Page(s): 1745 - 1750
  02/03/2011 Authors: Sabloff M; Chandy M; Wang Z; Logan BR; Ghavamzadeh A; Li C-K; Irfan SM; Bredeson CN; Cowan MJ; Gale RP
• EVALUATION OF HLA MATCHING REQUIREMENTS IN UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR NONMALIGNANT DISORDERS
  Volume: 17 Page(s): S173 - S173
  02/01/2011 Authors: Woolfrey A; Horan J; Wang T; Haagenson M; Ayas M; Baxter-Lowe LA; Bielorai B; Davies S; Dehn J; Frangoul H
• Acute Toxicities, Late Sequelae, and Quality of Survivorship in Children with Acute Myeloid Leukemia: The Impact of Allogeneic Stem Cell Transplant
  Page(s): 265 - 282
  01/01/2011 Authors: Byrne J; Horan J; Nicholson HS
• Safety and efficacy of targeted busulfan therapy in children undergoing myeloablative matched sibling donor BMT for sickle cell disease.
  Bone Marrow Transplant Volume: 46 Page(s): 27 - 33
  01/01/2011 Authors: McPherson ME; Hutcherson D; Olson E; Haight AE; Horan J; Chiang K-Y
• GVHD after haploidentical transplantation: a novel, MHC-defined rhesus macaque model identifies CD28- CD8+ T cells as a reservoir of breakthrough T-cell proliferation during costimulation blockade and sirolimus-based immunosuppression.
  Blood Volume: 116 Page(s): 5403 - 5418
  12/09/2010 Authors: Miller WP; Srinivasan S; Panoskaltsis-Mortari A; Singh K; Sen S; Hamby K; Deane T; Stempora L; Beus J; Turner A
• Platelet Transfusion Requirements Are Associated with Endothelial Cell Injury and Angiogenesis During Allogeneic Hematopoietic Stem Cell Transplantation
  Volume: 116 Page(s): 1433 - 1433
  11/19/2010 Authors: McPherson ME; Owusu BY; August KJ; Qayed M; Ilyles RH; Chiang K-Y; Khoury HJ; Ofori-Acquah SF; Horan J
• Outcome of Adolescents and Young Adults (AYAs) with Non-M3 Acute Myeloid Leukemia (AML) Treated on Children's Oncology Group (COG) Trials Compared to Cancer and Leukemia Group B (CALGB) and Southwest Oncology Group (SWOG) Trials
  Volume: 116 Page(s): 84 - 84
  11/19/2010 Authors: Franklin ARK; Alonzo TA; Gerbing RB; Donohue K; Othus M; Horan J; Estey EH; Larson RA; Woods WG
• Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors.
  Blood Volume: 116 Page(s): 4007 - 4015
  11/11/2010 Authors: Shaw PJ; Kan F; Woo Ahn K; Spellman SR; Aljurf M; Ayas M; Burke M; Cairo MS; Chen AR; Davies SM
• Effect of Red-Cell Transfusion Events on Transplant Related Mortality in Children Undergoing Hematopoietic Transplantation
  Volume: 50 Page(s): 21A - 21A
  09/01/2010 Authors: Andrews J; Horan J; Mertens AC; Jessup P; Guthrie S; Josephson CD
• Leukocyte adhesion deficiency-III in an African-American patient.
  Pediatr Blood Cancer Volume: 55 Page(s): 180 - 182
  07/15/2010 Authors: Sabnis H; Kirpalani A; Horan J; McDowall A; Svensson L; Cooley A; Merck T; Jobe S; Hogg N; Briones M
• Is the updated Schwartz formula appropriate for assessing renal function prior to hematopoietic stem cell transplantation?
  Pediatr Blood Cancer Volume: 55 Page(s): 199 - 201
  07/15/2010 Authors: Qayed M; Thompson A; Applegate K; Haight A; Rogatko A; Chiang K-Y; Horan J
• THE UPDATED SCHWARTZ FORMULA AS A SCREENING TEST FOR ABNORMAL KIDNEY FUNCTION PRIOR TO HEMATOPOIETIC STEM CELL TRANSPLANTATION
  Volume: 16 Page(s): S261 - S261
  02/01/2010 Authors: Qayed M; Thompson A; Applegate K; Haight A; Chiang K-Y; Horan J
• RIFAXIMIN FOR PREVENTING ACUTE GRAFT VERSUS HOST DISEASE: IMPACT ON PLASMA MARKERS OF INFLAMMATION AND T CELL ACTIVATION
  Volume: 16 Page(s): S309 - S309
  02/01/2010 Authors: Qayed M; Langston A; Chiang K-Y; Hilinski J; Cole C; McMillan S; Rowland P; Rogatko A; Horan J
• Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease.
  Biol Blood Marrow Transplant Volume: 16 Page(s): 263 - 272
  02/01/2010 Authors: Walters MC; Hardy K; Edwards S; Adamkiewicz T; Barkovich J; Bernaudin F; Buchanan GR; Bunin N; Dickerhoff R; Giller R
• Alcohol Use Among High School Students-Georgia, 2007 (Reprinted from MMWR, vol 58, pg 885-890, 2009)
  JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION Volume: 303 Page(s): 30 - 31
  01/06/2010 Authors: Kanny D; Horan J; Melstrom PC
• Reducing the Risk for Transplant Related Mortality After Allogeneic Hematopoietic Cell Transplantation: How Much Progress Has Been Made?
  Volume: 114 Page(s): 269 - 270
  11/20/2009 Authors: Horan J; Logan BR; Agovi M-A; Lazarus HM; Bacigalupo A; Ballen K; Martino R; Juckett MB; Khoury HJ; Bredeson C
• Risk factors affecting outcome of second HLA-matched sibling donor transplantations for graft failure in severe acquired aplastic anemia.
  Biol Blood Marrow Transplant Volume: 15 Page(s): 626 - 631
  05/01/2009 Authors: Horan JT; Carreras J; Tarima S; Camitta BM; Gale RP; Hale GA; Hinterberger W; Marsh J; Passweg JR; Walters MC
• Impact of disease risk on efficacy of matched related bone marrow transplantation for pediatric acute myeloid leukemia: the Children's Oncology Group.
  J Clin Oncol Volume: 26 Page(s): 5797 - 5801
  12/10/2008 Authors: Horan JT; Alonzo TA; Lyman GH; Gerbing RB; Lange BJ; Ravindranath Y; Becton D; Smith FO; Woods WG; Children's Oncology Group
• Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia.
  J Clin Oncol Volume: 26 Page(s): 5728 - 5734
  12/10/2008 Authors: Hahn T; McCarthy PL; Zhang M-J; Wang D; Arora M; Frangoul H; Gale RP; Hale GA; Horan J; Isola L
• Relationship of Targeted Busulfan Exposure to Engraftment in Children Undergoing Myeloablative Matched Sibling Donor Transplantation for Sickle Cell Disease
  Volume: 112 Page(s): 749 - 750
  11/16/2008 Authors: McPherson ME; Hutcherson D; Olson E; Haight A; Horan J; Chiang K-Y
• Evaluation of Human Leukocyte Antigen (HLA) Matching Requirements for Unrelated Peripheral Blood Stem Cell (PBSC) Transplantation
  Volume: 112 Page(s): 211 - 211
  11/16/2008 Authors: Woolfrey AE; Klein J; Haagenson MD; Spellman SR; Baltiwalla M; Gajewski JL; Hale GA; Horan J; Hurley CK; Kollman C
• EARLY DETECTION OF SEVERE ACUTE GRAFT-VERSUS-HOST DISEASE USING PLASMA MARKERS OF T-CELL ACTIVATION
  Volume: 14 Page(s): 133 - 133
  02/01/2008 Authors: August KJ; Chiang K-J; Bostick RM; Waller EK; Langston A; Khoury HJ; Moore KF; Worthington-White D; Rowland P; Horan JT
• Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research.
  Br J Haematol Volume: 137 Page(s): 479 - 485
  06/01/2007 Authors: Panepinto JA; Walters MC; Carreras J; Marsh J; Bredeson CN; Gale RP; Hale GA; Horan J; Hows JM; Klein JP
• Clinical outcomes and graft characteristics in pediatric matched sibling donor transplants using granulocyte colony-stimulating factor-primed bone marrow and steady-state bone marrow.
  Pediatr Transplant Volume: 11 Page(s): 279 - 285
  05/01/2007 Authors: Chiang K-Y; Haight A; Horan J; Olson E; Gartner A; Hartman D; Youssef S; Worthington-White D
• Effect of myeloablative bone marrow transplantation on growth in children with sickle cell anaemia: results of the multicenter study of haematopoietic cell transplantation for sickle cell anaemia.
  Br J Haematol Volume: 136 Page(s): 673 - 676
  02/01/2007 Authors: Eggleston B; Patience M; Edwards S; Adamkiewicz T; Buchanan GR; Davies SC; Dickerhoff R; Donfield S; Feig SA; Giller RH
• Prophylactic colony-stimulating factors in children receiving myelosuppressive chemotherapy: a meta-analysis of randomized controlled trials.
  Cancer Treat Rev Volume: 32 Page(s): 289 - 303
  06/01/2006 Authors: Wittman B; Horan J; Lyman GH
• A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission.
  Biol Blood Marrow Transplant Volume: 12 Page(s): 438 - 453
  04/01/2006 Authors: Marks DI; Forman SJ; Blume KG; Prez WS; Weisdorf DJ; Keating A; Gale RP; Cairo MS; Copelan EA; Horan JT
• Immunization to minor histocompatibility antigens on transfused RBCs through crosspriming into recipient MHC class I pathways.
  Blood Volume: 107 Page(s): 187 - 189
  01/01/2006 Authors: Zimring JC; Hair GA; Deshpande SS; Horan JT
• Transfusion of leukoreduced RBC results in immunization to minor histocompatibility antigens by crosspriming into recipient MHC class I pathways.
  Volume: 106 Page(s): 368A - 369A
  11/16/2005 Authors: Zimring JC; Hair GA; Deshpande SS; Horan JT
• Bone marrow transplantation for diamond-blackfan anemia.
  Biol Blood Marrow Transplant Volume: 11 Page(s): 600 - 608
  08/01/2005 Authors: Roy V; Prez WS; Eapen M; Marsh JCW; Pasquini M; Pasquini R; Mustafa MM; Bredeson CN; Non-Malignant Marrow Disorders Working Committee of the International Bone Marrow Transplant Registry
• Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience.
  Biol Blood Marrow Transplant Volume: 11 Page(s): 637 - 646
  08/01/2005 Authors: Wall DA; Carter SL; Kernan NA; Kapoor N; Kamani NR; Brochstein JA; Frangoul H; Goyal RK; Horan JT; Pietryga D
• Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin.
  Bone Marrow Transplant Volume: 35 Page(s): 171 - 177
  01/01/2005 Authors: Horan JT; Liesveld JL; Fenton P; Blumberg N; Walters MC
• Prophylactic colony-stimulating factors in pediatric patients receiving myelosuppressive chemotherapy: A meta-analysis of randomized controlled trials.
  Volume: 104 Page(s): 608A - 608A
  11/16/2004 Authors: Wittman B; Horan JT; Lyman GH
• A 2-year-old with atypical CML with a t(5;12)(q33;p13) treated successfully with imatinib mesylate.
  Leuk Res Volume: 28 Suppl 1 Page(s): S65 - S69
  05/01/2004 Authors: Wittman B; Horan J; Baxter J; Goldberg J; Felgar R; Baylor E; Cromwell B; Cross N; Bennett JM
• Survival after HLA-identical allogeneic peripheral blood stem cell and bone marrow transplantation for hematologic malignancies: meta-analysis of randomized controlled trials.
  Bone Marrow Transplant Volume: 32 Page(s): 293 - 298
  08/01/2003 Authors: Horan JT; Liesveld JL; Fernandez ID; Lyman GH; Phillips GL; Lerner NB; Fisher SG
• Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation.
  Semin Thromb Hemost Volume: 27 Page(s): 657 - 666
  12/01/2001 Authors: Horan JT; Francis CW
• Intensive chemotherapy versus bone marrow transplantation in pediatric acute myeloid leukemia: a matter of controversies.
  Blood Volume: 97 Page(s): 3671 - 3672
  06/01/2001 Authors: Creutzig U; Reinhardt D; Zimmermann M; Klingebiel T; Gadner H
• Intensive chemotherapy and bone marrow transplantation for children with acute myeloid leukemia.
  Blood Volume: 97 Page(s): 3672 - 3673
  06/01/2001 Authors: Horan J; Korones D
• Prothrombotic changes in hemostatic parameters and C-reactive protein in the elderly with winter acute respiratory tract infections.
  Thromb Haemost Volume: 85 Page(s): 245 - 249
  02/01/2001 Authors: Horan JT; Francis CW; Falsey AR; Kolassa J; Smith BH; Hall WJ
• Prediction of adverse outcomes in children with sickle cell disease.
  N Engl J Med Volume: 342 Page(s): 1612 - 1613
  05/25/2000 Authors: Horan J; Lerner N
• Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide.
  Bone Marrow Transplant Volume: 25 Page(s): 489 - 494
  03/01/2000 Authors: Duerst RE; Horan JT; Liesveld JL; Abboud CN; Zwetsch LM; Senf ES; Constine LS; Raubertas RF; Passarell JA; DiPersio JF
• Automated latex agglutination and ELISA testing yield equivalent D-dimer results in patients with recent myocardial infarction. THROMBO Research Investigators.
  Thromb Haemost Volume: 82 Page(s): 1412 - 1416
  11/01/1999 Authors: Marder VJ; Zareba W; Horan JT; Moss AJ; Kanouse JJ
• Allogeneic bone marrow transplantation (BMT) for children with leukemia: Cytoreduction with fractionated total body irradiation (fTBI), high-dose etoposide (VP) and cyclophosphamide (CY).
  BLOOD Volume: 90 Page(s): 4157 - 4157
  11/15/1997 Authors: Duerst RE; Horan J; Constine LS; Rapaport AP; Abboud CN; Packman CH; Rowe JM; Liesveld JL
• Management of children with sickle cell anemia and acute chest syndrome
  PEDIATRIC RESEARCH Volume: 39 Page(s): 922 - 922
  04/01/1996 Authors: Horan JT; Fox BK; Korones DN